Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011:2011:436856.
doi: 10.4061/2011/436856. Epub 2011 Jun 16.

Biopsy-Proven Acute Tubular Necrosis due to Vancomycin Toxicity

Affiliations
Case Reports

Biopsy-Proven Acute Tubular Necrosis due to Vancomycin Toxicity

Farheen Shah-Khan et al. Int J Nephrol. 2011.

Abstract

Vancomycin (VAN) has been associated with acute kidney injury (AKI) since it has been put into clinical use in the 1950's. Early reports of AKI were likely linked to the impurities of the VAN preparation. With the advent of the more purified forms of VAN, the incidence of AKI related to VAN were limited to acute interstitial nephritis (AIN) or as a potentiating agent to other nephrotoxins such as Aminoglycosides. VAN as the sole etiologic factor for nephrotoxic acute tubular necrosis (ATN) has not been described. Here, we report a case of biopsy-proven ATN resulting from VAN.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative photographs of the renal biopsy showing tubular damage secondary to drug toxicity. In both panels (a) and (b) a number of tubules show moderate degree of acute tubular necrosis (asterisks). Some of tubules contain hyaline or epithelial casts in their lumina (green arrows), while several tubules show vacuolization of their cytoplasm (green arrowheads). One of the glomerular afferent arteriole shows swollen endothelia and occlusive change (black arrow).

Similar articles

Cited by

References

    1. Vance-Bryan K, Guay DRP, Gilliland SS, Rodvold KA, Rotschafer JC. Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique. Antimicrobial Agents and Chemotherapy. 1993;37(3):436–440. - PMC - PubMed
    1. Winter ME. Basic Clinical Pharmacokinetics. 4th edition. Philadelphia, Pa, USA: Lippincott Williams & Wilkins; 2003.
    1. Bearden DT, Rodvold KA. Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics. Clinical Pharmacokinetics. 2000;38(5):415–426. - PubMed
    1. Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. American Journal of Health-System Pharmacy. 2009;66(1):82–98. - PubMed
    1. Farber BF, Moellering RC., Jr. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrobial Agents and Chemotherapy. 1983;23(1):138–141. - PMC - PubMed

Publication types

LinkOut - more resources